Korro Bio (KRRO) Asset Utilization Ratio (2020 - 2026)
Korro Bio's (KRRO) quarterly Asset Utilization Ratio came in at 0.03 in Q1 2026, up 14.91% YoY from 0.02 in Q1 2025, and down 44.36% on a QoQ basis from 0.05 in Q4 2025.
Korro Bio (KRRO) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
Korro Bio (KRRO) has 6 years of Asset Utilization Ratio data on file, last reported at 0.03 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 14.91% year-over-year to 0.03 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03 (up 14.91% YoY) and the FY2025 annual result came in at 0.04, up 271.06% from the prior year.
- Asset Utilization Ratio declined to 0.03 in Q1 2026, from 0.05 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.05 in Q1 2022 to a low of 0.01 in Q4 2024.
- A 4-year average of 0.03 and a median of 0.03 in 2025 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio plunged 60.41% — and 2025, when it soared 380.72%.
- Tracing KRRO's Asset Utilization Ratio over 4 years: stood at 0.05 in 2022, then sank by 82.02% to 0.01 in 2024, then soared by 380.72% to 0.05 in 2025, then tumbled by 44.36% to 0.03 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.03 (Q1 2026), 0.05 (Q4 2025), and 0.04 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - | 0.13 |
| 10 | Korro Bio | 230.63 Mn | 115.59 Mn | - | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.03 |
| Dec 31, 2025 | 0.05 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.03 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.01 |
| Mar 31, 2022 | 0.05 |
| Dec 31, 2021 | 0.07 |
| Sep 30, 2021 | 0.11 |
| Jun 30, 2021 | 0.15 |
| Mar 31, 2021 | 0.14 |
| Dec 31, 2020 | 0.15 |
| Sep 30, 2020 | 0.14 |
| Jun 30, 2020 | 0.21 |